Holstein A - Search Results

1

Conversations and Reactions Around Severe Hypoglycaemia (CRASH): Results from the German Cohort of a Global Survey of People with Type 1 Diabetes or Insulin-Treated Type 2 Diabetes and Caregivers.

Mönnig E, Spaepen E, Osumili B, Mitchell BD, Snoek F, Peyrot M, Kern W, Holstein A. Mönnig E, et al. Among authors: holstein a. Exp Clin Endocrinol Diabetes. 2022 Mar;130(3):145-155. doi: 10.1055/a-1310-7963. Epub 2020 Dec 23. Exp Clin Endocrinol Diabetes. 2022. PMID: 33368091

2

Lipodystrophy and metabolic disorders as complication of antiretroviral therapy of HIV infection.

Holstein A, Plaschke A, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2001;109(8):389-92. doi: 10.1055/s-2001-18990. Exp Clin Endocrinol Diabetes. 2001. PMID: 11748485 Review.

3

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.

Holstein A, Plaschke A, Egberts EH. Holstein A, et al. Diabetes Metab Res Rev. 2001 Nov-Dec;17(6):467-73. doi: 10.1002/dmrr.235. Diabetes Metab Res Rev. 2001. PMID: 11757083 Clinical Trial.

4

Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.

Holstein A, Plaschke A, Hammer C, Egberts EH. Holstein A, et al. Eur J Clin Pharmacol. 2003 Jun;59(2):91-7. doi: 10.1007/s00228-003-0592-4. Epub 2003 Apr 16. Eur J Clin Pharmacol. 2003. PMID: 12698302

5

Clinical characterisation of severe hypoglycaemia--a prospective population-based study.

Holstein A, Plaschke A, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2003 Sep;111(6):364-9. doi: 10.1055/s-2003-42728. Exp Clin Endocrinol Diabetes. 2003. PMID: 14520604

6

Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.

Holstein A, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):405-14. doi: 10.1055/s-2003-44287. Exp Clin Endocrinol Diabetes. 2003. PMID: 14614647 Review.

7

Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.

Holstein A, Hammer C, Plaschke A, Ptak M, Kuhn J, Diekmann J, Kleesiek K, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2004 Sep;112(8):429-34. doi: 10.1055/s-2004-821188. Exp Clin Endocrinol Diabetes. 2004. PMID: 15372362

8

Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.

Holstein A, Plaschke A, Ptak M, Egberts EH, El-Din J, Brockmöller J, Kirchheiner J. Holstein A, et al. Br J Clin Pharmacol. 2005 Jul;60(1):103-6. doi: 10.1111/j.1365-2125.2005.02379.x. Br J Clin Pharmacol. 2005. PMID: 15963101 Free PMC article.

9

The E23K variant of KCNJ11 and the risk for severe sulfonylurea-induced hypoglycemia in patients with type 2 diabetes.

Holstein A, Hahn M, Stumvoll M, Kovacs P. Holstein A, et al. Horm Metab Res. 2009 May;41(5):387-90. doi: 10.1055/s-0029-1192019. Epub 2009 Feb 12. Horm Metab Res. 2009. PMID: 19214942

10

Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study.

Holstein A, Patzer OM, Machalke K, Holstein JD, Stumvoll M, Kovacs P. Holstein A, et al. Among authors: holstein jd. Diabetes Care. 2012 May;35(5):972-5. doi: 10.2337/dc11-1470. Epub 2012 Mar 12. Diabetes Care. 2012. PMID: 22410817 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters